cardiovascular pharma

Advertisement

cGxPJobs Banner

HUYABIO Reports Positive Phase 1 Data for AF Drug HBI-3000

SAN DIEGO | January 6, 2026 — HUYABIO International has announced positive Phase 1 clinical results for HBI-3000, a...

By cGxPwire Editor
January 6, 2026

Read More

Advertisement

cGxPJobs

Directory